GSK hits back in high-stakes RSV vaccine game, posting phase 3 data that suggest it has edge on Pfizer Sony, Lexie Hearing roll out first batches of over-the-counter hearing aids alongside FDA green light Novartis to lay off 400 at Dublin campus amid global restructuring Hospital and health system transactions remain infrequent but hefty in Q3 2022: report Relmada’s stock sinks after depression drug defeated by ‘outperforming’ placebo Roche launches ‘2.0’ antigen tests for COVID’s long road ahead AstraZeneca hit with small fine in Korea over plot to stall generic of lucrative cancer med Humana joins forces with USAA for new co-branded MA plan for veterans 10 months after first mega round, Glick's Odyssey raises $168M to gear up for entering clinic Sanofi sells 50-year-old manufacturing plant in Japan to CDMO Adragos Pharma Nevro nabs FDA approval for spinal cord stimulator that uses AI to personalize pain treatment Otonomy’s phase 2 backup plan flames out, prompting search for new options Brave Health nabs $40M to scale up virtual mental health services for Medicaid members | 